Leading Edge Research for the Isolation of Highly effective Formulations for the Treatment of Chronic Medical Disorders
Verde Science (VRCI-OTCQB) has established a high level Research and Development Team with expertise in Bioprocess Technology, Nanotechnology, Molecular Virology and Immunology, Pharmacology and Medical Device Design, which is focused on the isolation of new drugs and delivery systems for the treatment of a variety of medical issues, and the development of novel tests for the screening of emerging and contemporary medical issues.
Our initial primary area of investigation is Cannabis-based extracts to isolate and develop formulations for the effective treatment of specific medical conditions such as, migraines and pain management, loss of appetite due to chemotherapy treatment, multiple sclerosis, and seizures. Our scientists have identified several molecules in the Marijuana plant that have significant promise for the development important pharmaceutical formulations.
Research will begin in India, where costs are much lower, and our team of scientists and alliance partners can respond much faster to new developments. Our expedited and low cost approach sets Verde Science apart from others in the biotech space.
- October 19, 2015 - 9:15 amRenown doctor to Lead Verde Science’s Huntington Disease Study
- October 12, 2015 - 6:15 amVerde Science to Sponsor/Present at the Huntington Study Group Annual Conference
- October 9, 2015 - 2:00 pmVerde Science Announces Plan to Study Cannabis Preparation for Treatment of Huntingdon’s Disease